Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis

This publication has 29 references indexed in Scilit:

• Current Prospects for the Fluoroquinolones as First-Line Tuberculosis Therapy
  Antimicrobial Agents and Chemotherapy, 2011
• Deciphering the Mode of Action of the Synthetic Antimicrobial Peptide Bac8c
  Antimicrobial Agents and Chemotherapy, 2011
• Induction of β-defensins byl-isoleucine as novel immunotherapy in experimental murine tuberculosis
  Clinical and Experimental Immunology, 2011
• Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis
  The American Journal of Clinical Nutrition, 2010
• Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis
  Clinical and Experimental Immunology, 2010
• Susceptibility to Infectious Diseases Based on Antimicrobial Peptide Production
  Infection and Immunity, 2009
• Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
  Chest, 2009
• The Potential Role of Lung Epithelial Cells and β‐defensins in Experimental Latent Tuberculosis
  Scandinavian Journal of Immunology, 2008
• β‐Defensin Gene Expression during the Course of Experimental Tuberculosis Infection
  The Journal of Infectious Diseases, 2006
• Antimicrobial peptides of multicellular organisms
  Nature, 2002